In summary, the AAV9-hGFAP-Cre-ΔWPRE system showed high efficiency and specificity for MG labeling, providing a useful tool for in vivo MG-lineage tracing in eye development, as well as for the development of MG-targeted therapeutics. The gene discussed is HGFAC; the disease is myasthenia gravis.